---

title: Ectopic Pregnancy and Methotrexate
authors:
    - Michelle Lin, MD
created: 2011/11/11
updates:
categories:
    - OBGYN
---

# Methotrexate for Ectopic Pregnancy

## Methotrexate (MTX)

**Background**

- Dihydrofolate reductase inhibitor
- Overall success rate for treating ectopic pregnancy = 71-94%
- Success rate of single-dose MTX for beta-hCG >5,000 mIU/mL = 85.7% 

**Side Effects**

- Abdominal pain
- Nausea/vomiting
- Stomatitis    

## Eligibility / Contraindications for MTX in Ectopic Pregnancy

**Eligibility Criteria: (Need to fulfill all criteria)**

- High clinical suspicion or confirmed ectopic pregnancy
- Hemodynamically stable
- Unruptured mass
- Able to comply with close follow-up
- Normal creatinine, liver transaminases, WBC, hematocrit, and platelet counts 

**Contraindications:**

- Breastfeeding
- Overt or lab evidence of immunodeficiency
- Alcoholism, alcoholic or chronic liver disease
- Preexisting blood dyscrasias or significant anemia 
- Known sensitivity to MTX
- Active pulmonary disease
- Peptic ulcer disease
- Hepatic, renal, or hematologic dysfunction
- Gestational sac >3.5 cm on U/S (relative contraindication) 
- Embryonic cardiac motion on U/S (relative contraindication) 

## Single-Dose Regimen

- Day 1: <span class="drug">Methotrexate</span> 50 mg/m2 IM

**Follow up with obstetrician:**

- Days 4 and 7: Measure beta-hCG
- Between Days 4 and 7: Check for 15% beta-hCG decrease
- Measure beta-hCG weekly until non-pregnant level
- If beta-hCG dose not decrease by >15% as expected, re-dose 50 mg/m2 IM and repeat B-hCG on days 4 and 7 after 2nd dose. 

## Alternative Regimens

- **Two-Dose** and **Fixed Multidose** regimens available as proposed by ACOG guidelines - Consider for beta-hCG level >5,000 mIU/mL

## References

- ACOG Practice Bulletin No. 94:Medical management of ectopic pregnancy. Obstet Gynecology. 2008; 111(6):1479-85. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18515537)]
